Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
about
Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicineLymphoma: immune evasion strategiesVascular endothelial growth factor-related pathways in hemato-lymphoid malignancies.VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphoma.Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours.The role of angiogenesis in human non-Hodgkin lymphomas.Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell.Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR geneAngiogenesis and antiangiogenic therapy in non-Hodgkin's lymphomaCD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma.Emerging drugs for Hodgkin's lymphoma.Targetable molecular pathways in classical Hodgkin's lymphoma.Targeting the vascular endothelial growth factor in hematologic malignancies.Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma.Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma.Mechanisms underlying the association between obesity and Hodgkin lymphoma.Role of vascular endothelial growth factor C in classical Hodgkin lymphoma.The hypoxia signalling pathway in haematological malignancies.Tissue-microarray based immunohistochemical analysis of survival pathways in nodular sclerosing classical Hodgkin lymphoma as compared with Non-Hodgkin's lymphoma.Everolimus as a single agent in refractory or relapsed Hodgkin's lymphoma: the Brazilian Named Patient Program Experience.Microvessel Density Is Associated with VEGF and α-SMA Expression in Different Regions of Human Gastrointestinal Carcinomas.Focal segmental glomerulosclerosis in a patient with mantle cell lymphoma.Prognostic significance of immunohistochemical expression of the angiogenic molecules vascular endothelial growth factor-A, vascular endothelial growth factor receptor-1 and vascular endothelial growth factor receptor-2 in patients with classical HoPlasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b(+)/F4/80(+) myeloid cell recruitment.Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PdEGF) in classical Hodgkin lymphoma (HL).A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma.Expression of cyclooxygenase-2 in Hodgkin's lymphoma: its role in cell proliferation and angiogenesis.Serum VEGF as a significant marker of treatment response in hodgkin lymphoma.The Microenvironment in Epstein-Barr Virus-Associated Malignancies.
P2860
Q26796247-8F672B30-3C2B-4550-95A2-7C4964507EA5Q28080705-F4DCEC53-130C-4D77-8C9F-B0DAD3EE1D82Q33874179-25E32210-D98C-4544-AAA2-D3D69952AF5DQ34086827-33181E1D-A68B-4774-985A-591018CE36B3Q35587630-5636C7AC-F838-489C-8C51-8475434D99CFQ36670881-E62A81D5-0EE9-4300-B877-3C0CB8C9DDDFQ37004635-596D61AA-B187-4EEC-9F0F-343B8C0B4E24Q37216463-438229C0-AF47-40A9-A0A0-A8050AB7387DQ37321798-25DE9B30-CB39-40BE-AC96-4C66F0A03355Q37529430-B69BB66F-C8FD-4857-AE47-E91C28F86A0FQ37772513-D0DF6220-9BE6-4E6F-AD78-2750D580AABFQ37825891-2421EE21-7EBA-477F-AD5E-FCA38B075093Q38038645-3E299A75-46B7-49E0-A010-6C08BBEB60A2Q38751343-2A8A0AE5-F115-4BF8-9E62-5DB0239C3676Q38868904-17DF859F-694E-4C26-809B-F1AC69A58A50Q38910560-FA123433-6D5A-48C2-BA51-510D68EDC846Q38968332-34209FC8-010D-416D-AB49-245F73394B34Q39246376-E4FF149D-EFCB-49E8-AFFA-6D9819F4E234Q39868627-1E67ECE3-1698-469B-99C7-4BA3F4F01D84Q41491132-438DB225-0C84-46A4-9065-B946211FD69DQ42579675-27D81453-A79F-4CFD-BBED-293488A61CF8Q43015205-BAC75A47-0EF0-41C3-8C10-272726D72BE6Q43883383-297439FE-BAAE-4C00-8AF3-4D2671C467B4Q45989102-A55CC09E-0D93-4DC9-B1A6-142BBFFC25CEQ46193990-EFA0ECA0-CA08-42B4-BBDA-7EBA45A09555Q46830786-73DE83F9-40C0-4B97-BCC9-B0F332DBFCF8Q46979566-AF600F85-2F5E-4081-9D4E-FD79B34D0FDFQ53340666-8C7E6D47-B491-450E-8A2D-690D56E7D778Q53485702-536AFEBE-A9D8-41A9-9D7B-27FFE7FDB475Q54236409-06239427-F1AA-4E17-AD7B-1CA872019D3C
P2860
Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Vascular endothelial growth fa ...... rg cells in Hodgkin's disease.
@en
type
label
Vascular endothelial growth fa ...... rg cells in Hodgkin's disease.
@en
prefLabel
Vascular endothelial growth fa ...... rg cells in Hodgkin's disease.
@en
P2093
P2860
P356
P1476
Vascular endothelial growth fa ...... rg cells in Hodgkin's disease.
@en
P2093
Christos Kittas
Daphne C Tan
George Mariatos
Helen Turley
Ipatia A Doussis-Anagnostopoulou
Kate L Talks
Kevin C Gatter
Paul Debnam
Vassilis Gorgoulis
P2860
P304
P356
10.1002/PATH.1151
P577
2002-08-01T00:00:00Z